French vaccines developer Valneva announced that the US Food and Drug Administration (FDA) has removed its recommended pause ...

A Californian company developing new treatments to help organ transplant patients keep their transplanted organs healthy over the long term.

US clinical-stage biotech Keros Therapeutics has announced a strategic realignment designed to reallocate resources towards ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by ...

Drug-resistant infections now claim more lives each year than HIV/AIDS or malaria, and the toll is rising. The World Health Organization warns that without urgent action, antimicrobial resistance (AMR ...

Danish biotech Genmab (Nasdaq: GMAB) and US partner AbbVie (NYSE: ABBV) have reported a decisive win in a Phase III study of ...